Leukaemia inhibitory factor receptor and gp130 in the human Fallopian tube and endometrium before and after mifepristone treatment and in the human preimplantation embryo

Molecular Human Reproduction

Volumn 13, Issue 6, 2007, Pages 391-397

  Wånggren, Kjell ^a,b   Lalitkumar, P G ^a   Hambiliki, F ^b,c   Stabi B ^a   Gemzell Danielsson, K ^a   Stavreus Evers, A ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; LEUKEMIA INHIBITORY FACTOR RECEPTOR; LUTEINIZING HORMONE; MIFEPRISTONE; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; BLASTOCYST; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNER CELL MASS; NUCLEOTIDE SEQUENCE; OVULATION; PREIMPLANTATION EMBRYO; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; UTERINE TUBE;

ADULT; BLASTOCYST; CYTOKINE RECEPTOR GP130; ENDOMETRIUM; FALLOPIAN TUBES; FEMALE; HORMONE ANTAGONISTS; HUMANS; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; MIFEPRISTONE;

EID: 34447526284     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam013     Document Type: Article

References (59)

1. Aghajanova L, Stavreus-Evers A, Nikas Y et al. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium. Fertil Steril 2003;79(Suppl 1), 808-814.
2. Arici A, Engin O, Attar E et al. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in human endometrium. J Clin Endocrinol Metab 1995;80:1908-1915.
3. Arici A, Oral E, Bahtiyar O et al. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells. Hum Reprod 1997;12:1233-1239.
4. Attar E, Ozsait B, Bulgurcuoglu S et al. Effect of leukaemia inhibitory factor on long-term sperm motility and survival. Reprod Biomed Online 2003;7:71-74.
5. Auernhammer CJ, Melmed S. Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 2000;21:313-345.
6. Austgulen R, Arntzen KJ, Vatten LJ et al. Detection of cytokines (interleukin-1, interleukin-6, transforming growth factor-beta) and soluble tumour necrosis factor receptors in embryo culture fluids during in-vitro fertilization. Hum Reprod 1995;10:171-176.
7. Cameron ST, Critchley HO, Buckley CH et al. Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation. Fertil Steril 1997;67 1046-1053.
8. Cekan SZ, Beksac MS, Wang E et al. The prediction and/or detection of ovulation by means of urinary steroid assays. Contraception 1986;33: 327-345.
9. Charnock-Jones DS, Sharkey AM, Fenwick P et al. Leukaemia inhibitory factor mRNA concentration peaks in human endometrium at the time of implantation and the blastocyst contains mRNA for the receptor at this time. J Reprod Fertil 1994;101:421-426.
10. Chen HF, Shew JY, Ho HN et al. Expression of leukemia inhibitory factor and its receptor in preimplantation embryos. Fertil Steril 1999;72:713-719.
11. Cheng JG, Rodriguez CI, Stewart CL. Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: Towards a molecular understanding of "the window of implantation". Rev Endocr Metab Disord 2002;3:119-126.
12. Christow A, Sun X, Gemzell-Danielsson K. Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube. Mol Hum Reprod 2002;8:333-340.
13. Classen-Linke I, Muller-Newen G, Heinrich PC et al. The cytokine receptor gp130 and its soluble form are under hormonal control in human endometrium and decidua. Mol Hum Reprod 2004;10:495-504.
14. Croxatto HB, Ortiz ME, Diaz S et al. Studies on the duration of egg transport by the human oviduct. II. Ovum location at various intervals following luteinizing hormone peak. Am J Obstet Gynecol 1978;132:629-634.
15. Cullinan EB, Abbondanzo SJ, Anderson PS et al. Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci USA 1996;93:3115-3120.
16. Danielsson KG, Swahn ML, Bygdeman M. The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase-an immunohistochemical study. Hum Reprod 1997;12:1293-1297.
17. De Ziegler D, Fanchin R, Massonneau M et al. Hormonal control of endometrial receptivity. The egg donation model and controlled ovarian hyperstimulation. Ann NY Acad Sci 1994;734:209-220.
18. Dunglison GF, Barlow DH, Sargent IL. Leukaemia inhibitory factor significantly enhances the blastocyst formation rates of human embryos cultured in serum-free medium. Hum Reprod 1996;11:191-196.
19. Fry RC, Batt PA, Fairclough RJ et al. Human leukemia inhibitory factor improves the viability of cultured ovine embryos. Biol Reprod 1992;46:470-474.
20. Gearing DP. The leukemia inhibitory factor and its receptor. Adv Immunol 1993;53:31-58.
21. Gemzell-Danielsson K, Hamberg M. The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2 alpha concentrations. Hum Reprod 1994;9 1626-1630.
22. Gemzell-Danielsson K, Swahn ML, Svalander P et al. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod 1993;8:870-873.
23. Hambartsoumian E. Endometrial leukemia inhibitory factor (LIF) as a possible cause of unexplained infertility and multiple failures of implantation. Am J Reprod Immunol 1998;39:137-143.
24. Hombach-Klonisch S, Kehlen A, Fowler PA et al. Regulation of functional steroid receptors and ligand-induced responses in telomerase-immortalized human endometrial epithelial cells. J Mol Endocrinol 2005;34:517-534.
25. Jabbour HN, Kelly RW, Fraser HM et al. Endocrine regulation of menstruation. Endocr Rev 2006;27:17-46.
26. Keltz MD, Attar E, Buradagunta S. et al. Modulation of leukemia inhibitory factor gene expression and protein biosynthesis in the human fallopian tube. Am J Obstet Gynecol 1996;175:1611-1619.
27. Klein-Hitpass L, Cato AC, Henderson D et al. Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells. Nucl Acids Res 1991;19:1227-1234.
28. Kojima K, Kanzaki H, Iwai M et al. Expression of leukemia inhibitory factor in human endometrium and placenta. Biol Reprod 1994;50:882-887.
29. Laird SM, Tuckerman EM, Dalton CF et al. The production of leukaemia inhibitory factor by human endometrium: Presence in uterine flushings and production by cells in culture. Hum Reprod 1997; 12:569-574.
30. Lass A, Weiser W, Munafo A et al. Leukemia inhibitory factor in human reproduction. Fertil Steril 2001;76:1091-1096.
31. Lavranos TC, Rathjen PD, Seamark RF. Trophic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos. J Reprod Fertil 1995;105: 331-338.
32. Li HZ, Sun X, Stavreus-Evers A et al. Effect of mifepristone on the expression of cytokines in the human Fallopian tube. Mol Hum Reprod 2004;10:489-493.
33. Martel D, Psychoyos A. Estrogen receptors in the nidatory sites of the rat endometrium. Science 1981;211:1454-1455.
34. Matsui Y, Toksoz D, Nishikawa S et al. Effect of Steel factor and leukaemia inhibitory factor on murine primordial germ cells in culture. Nature 1991;353:750-752.
35. Mitchell MH, Swanson RJ, Oehninger S. In vivo effect of leukemia inhibitory factor (LIF) and an anti-LIF polyclonal antibody on murine embryo and fetal development following exposure at the time of transcervical blastocyst transfer. Biol Reprod 2002;67 460-464.
36. Modric T, Kowalski AA, Green ML et al. Pregnancy-dependent expression of leukaemia inhibitory factor (LIF), LIF receptor-beta and interleukin-6 (IL-6) messenger ribonucleic acids in the porcine female reproductive tract. Placenta 2000;21:345-353.
37. Ni H, Ding NZ, Harper MJ et al. Expression of leukemia inhibitory factor receptor and gp130 in mouse uterus during early pregnancy. Mol Reprod Dev 2002;63:143-150.
38. Nikas G, Drakakis P, Loutradis D et al. Uterine pinopodes as markers of the 'nidation window' in cycling women receiving exogenous oestradiol and progesterone. Hum Reprod 1995;10:1208-1213.
39. Olivennes F, Ledee-Bataille N, Samama M et al. Assessment of leukemia inhibitory factor levels by uterine flushing at the time of egg retrieval does not adversely affect pregnancy rates with in vitro fertilization. Fertil Steril 2003;79:900-904.
40. Passavant C, Zhao X, Das SK et al. Changes in uterine expression of leukemia inhibitory factor receptor gene during pregnancy and its up-regulation by prolactin in the western spotted skunk. Biol Reprod 2000;63:301-307.
41. Pauerstein CJ, Eddy CA. The role of the oviduct in reproduction; our knowledge and our ignorance. J Reprod Fertil 1979;55:223-229.
42. Rauch M, Loosfelt H, Philibert D et al. Mechanism of action of an antiprogesterone, RU486, in the rabbit endometrium. Effects of RU486 on the progesterone receptor and on the expression of the uteroglobin gene. Eur J Biochem 1985;148:213-218.
43. Reinhart KC, Dubey RK, Mummery CL et al. Synthesis and regulation of leukaemia inhibitory factor in cultured bovine oviduct cells by hormones. Mol Hum Reprod 1998;4:301-308.
44. Robinson RC, Grey LM, Staunton D et al. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding. Cell 1994;77:1101-1116.
45. Seli E, Kayisli UA, Cakmak H et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod 2005;20 3012-3017.
46. Senturk LM, Arici A. Leukemia inhibitory factor in human reproduction. Am J Reprod Immunol 1998;39:144-151.
47. Sharkey AM, Dellow K, Blayney M et al. Stage-specific expression of cytokine and receptor messenger ribonucleic acids in human preimplantation embryos. Biol Reprod 1995;53:974-981.
48. Sherwin JR, Smith SK, Wilson A et al. Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J Clin Endocrinol Metab 2002;87:3953-3960.
49. Smith AG, Nichols J, Robertson M et al. Differentiation inhibiting activity (DIA/LIF) and mouse development. Dev Biol 1992;151 339-351.
50. Stewart CL, Kaspar P, Brunet LJ et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 1992;359:76-79.
51. Strandell A, Lindhard A, Waldenstrom U et al. Hydrosalpinx and IVF outcome: Cumulative results after salpingectomy in a randomized controlled trial. Hum Reprod 2001;16:2403-2410.
52. Strandell A, Thorburn J, Wallin A. The presence of cytokines and growth factors in hydrosalpingeal fluid. J Assist Reprod Genet 2004;21 241-247.
53. Sun X, Christow A, Marions L et al. Progesterone receptor isoform B in the human fallopian tube and endometrium following mifepristone. Contraception 2003;67:319-326.
54. Teutsch G, Ojasoo T, Raynaud JP. 11 beta-substituted steroids, an original pathway to antihormones. J Steroid Biochem 1988;31 549-565.
55. Xu J, Cheung TM, Chan ST et al. Human oviductal cells reduce the incidence of apoptosis in cocultured mouse embryos. Fertil Steril 2000;74:1215-1219.
56. Xu JS, Chan ST, Ho PC et al. Coculture of human oviductal cells maintains mitochondrial function and decreases caspase activity of cleavage-stage mouse embryos. Fertil Steril 2003;80:178-183.
57. Xu JS, Cheung TM, Chan ST et al. Temporal effect of human oviductal cell and its derived embryotrophic factors on mouse embryo development. Biol Reprod 2001;65:1481-1488.
58. Yamamori T. Molecular mechanisms for generation of neural diversity and specificity: Roles of polypeptide factors in development of postmitotic neurons. Neurosci Res 1992;12:545-582.
59. Yoon IB, King TM. A preliminary and intermediate report on a new laparoscopic tubal ring procedure. J Reprod Med 1975;15 54-56.